Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides

References

• Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22–29.
   PubMedGoogle Scholar
• Luepke KH, Suda KJ, Boucher H, et al. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications. Pharmacotherapy. 2017;37(1):71–84.
   PubMed Web of Science ®Google Scholar
• Spellberg B. The future of antibiotics. Crit Care. 2014;18(3):228.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Park SJ, Mishig-Ochir T, Lee BJ. Antimicrobial peptides: therapeutic potentials. Expert Rev Anti Infect Ther. 2014;12(12):1477–1486.
   PubMed Web of Science ®Google Scholar
• Sun E, Belanger CR, Haney EF, Hancock REW. Host defense (antimicrobial) peptides. In: Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Woodhead Publishing. 2018:253–285.
   Google Scholar
• Strempel N, Strehmel J, Overhage J. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections. Curr Pharm Des. 2015;21(1):67–84.
   PubMed Web of Science ®Google Scholar
• Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016;6:194.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Scocchi M, Pomponio S, et al. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011;32(9):1807–1814.
   PubMed Web of Science ®Google Scholar
• Malanovic N, Leber R, Schmuck M, et al. Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systems. Biochim Biophys Acta. 2015;1848(10):2437–2447.
   PubMed Web of Science ®Google Scholar
• Peters BM, Shirtliff ME, Jabra-Rizk MA. Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog. 2010;6(10):e1001067.
   PubMed Web of Science ®Google Scholar
• Algburi A, Zhang Y, Weeks R, et al. Gemini cationic amphiphiles control biofilm formation by bacterial vaginosis pathogens. Antimicrob Agents Chemother. 2017;61(12):e00650–e00717.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Ghosh JK. Introduction of a lysine residue promotes aggregation of temporin L in lipopolysaccharides and augmentation of its antiendotoxin property. Antimicrob Agents Chemother. 2013;57(6):2457–2466.
   PubMed Web of Science ®Google Scholar
• Song R, Shi Q, Yang P, Wei R. Identification of antibacterial peptides from Maillard reaction products of half-fin anchovy hydrolysates/glucose via LC-ESI-QTOF-MS analysis. J Funct Foods. 2017;36:387–395.
   Web of Science ®Google Scholar
• Faccone D, Veliz O, Corso A, et al. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates. Eur J Med Chem. 2014;71:31–35.
   PubMed Web of Science ®Google Scholar
• Lear S, Cobb SL. Pep-Calc.com: a set of web utilities for the calculation of peptide and peptoid properties and automatic masss spectral peak assignment. J Comput Aided Mol Des. 2016;30(3):271–277.
   PubMed Web of Science ®Google Scholar
• Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31(13):3784–3788.
   PubMed Web of Science ®Google Scholar
• Söding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 2005;33(Web Server Issue):W244–W248.
   PubMed Web of Science ®Google Scholar
• Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Bio. 1993;234(3):779–815.
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Tarazi S, Abu-Alhaijaa A, et al. Enhanced antimicrobial activity of AamAP1-Lysine, a novel synthetic peptide analog derived from the scorpion venom peptide AamAP1. Pharmaceuticals (Basel). 2014;7(5):502–516.
   PubMedGoogle Scholar
• Ouhara K, Komatsuzawa H, Kawai T, et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother. 2008;61(6):1266–1269.
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Qaoud MT, Khalil Mohammed G, et al. Antimicrobial and antibiofilm activity of UP-5, an ultrashort antimicrobial peptide designed using only arginine and biphenylalanine. Pharmaceuticals (Basel). 2018;11(1):pii:E3.
   PubMedGoogle Scholar
• Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51(8):4151–4155.
   PubMed Web of Science ®Google Scholar
• Wang W, Tao R, Tong Z, et al. Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms. Peptides. 2012;33(2):212–219.
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Tarazi S, Alsheyab F, Al-Balas Q, Mukattash T. Antimicrobial and antibiofilm activity of mauriporin, a multifunctional scorpion venom peptide. Int J Pept Res Ther. 2014;20(4):397–408.
   Web of Science ®Google Scholar
• World Health Organization. Antimicrobial Resistance. Geneva: World Health Organization. Available from: http://www.who.int/mediacentre/factsheets/fs194/en/. Accessed November 13, 2017.
   Google Scholar
• Schäberle TF, Hack IM. Overcoming the current deadlock in antibiotic research. Trends Microbiol. 2014;22(4):165–167.
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433.
   PubMed Web of Science ®Google Scholar
• Leung E, Weil DE, Raviglione M, Nakatani H. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011;89(5):390–392.
   PubMed Web of Science ®Google Scholar
• Rolain JM, Canton R, Cornaglia G. Emergence of antibiotic resistance: need for a new paradigm. Clin Microbiol Infect. 2012;18(7):615–616.
   PubMed Web of Science ®Google Scholar
• Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2012;56(12):6366–6371.
   PubMed Web of Science ®Google Scholar
• Marr AK, Gooderham WJ, and Hancock RE. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol. 2006;6(5):468–472.
   PubMed Web of Science ®Google Scholar
• Trabocchi A, Guarna A. The basics of peptidomimetics. In: Peptidomimetics in Organic and Medicinal Chemistry: The Art of Transforming Peptides in Drugs. John Wiley & Sons, Ltd. 2014:1–17.
   Google Scholar
• Liskamp RMJ. Conformationally restricted amino acids and dipeptides, (non)peptidomimetics and secondary structure mimetics. Recueil des Travaux Chimiques des Pays-Bas. 1994;113(1):1–19.
   Google Scholar
• Olson GL, Bolin DR, Bonner MP, et al. Concepts and progress in the development of peptide mimetics. J Med Chem. 1993;36(21):3039–3049.
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Tarazi S, Al-Fandi M, Abuilhaija A, Al-Balas Q, Abu-Awad A. The design and functional characterization of the antimicrobial and antibiofilm activities of BMAP27-melittin, a rationally designed hybrid peptide. Int J Pept Res Ther. 2015;21(2):165–177.
   Web of Science ®Google Scholar
• Huang Y, Huang J, Chen Y. Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell. 2010;1(2):143–152.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2012;32(2):143–171.
   PubMed Web of Science ®Google Scholar
• Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. 2011;11(1):37–51.
   PubMed Web of Science ®Google Scholar
• Lau QY, Ng FM, Cheong JW, et al. Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure–activity relationship study. Eur J Med Chem. 2015;105:138–144.
   PubMed Web of Science ®Google Scholar
• Wang G. Determination of solution structure and lipid micelle location of an engineered membrane peptide by using one NMR experiment and one sample. Biochim Biophys Acta. 2007;1768(12):3271–3281.
   PubMed Web of Science ®Google Scholar
• Huang Y, He L, Li G, Zhai N, Jiang H, Chen Y. Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell. 2014;5(8):631–642.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Azmi S, Srivastava RM, et al. Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity. Biochemistry. 2009;48(46):10905–10917.
   PubMed Web of Science ®Google Scholar
• Ruden S, Hilpert K, Berditsch M, Wadhwani P, Ulrich AS. Synergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptides. Antimicrob Agents Chemotherapy. 2009;53(8):3538–3540.
   PubMed Web of Science ®Google Scholar
• Maróti G, Kereszt A, Kondorosi E, Mergaert P. Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol. 2011;162(4):363–374.
   PubMed Web of Science ®Google Scholar
• Yang P, Ramamoorthy A, Chen Z. Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy. Langmuir. 2011;27(12):7760–7767.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Sun Y, et al. In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates. Curr Microbiol. 2014;68(6):685–692.
   PubMed Web of Science ®Google Scholar
• Hirt H, Gorr SU. Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57(10):4903–4910.
   PubMed Web of Science ®Google Scholar
• Mishra B, Wang G. Individual and combined effects of engineered peptides and antibiotics on Pseudomonas aeruginosa biofilms. Pharmaceuticals (Basel). 2017;10(3):pii:E58.
   PubMedGoogle Scholar
• Høiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011;3(2):55–65.
   PubMed Web of Science ®Google Scholar
• Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res. 2002;66(2):86–92.
   PubMed Web of Science ®Google Scholar
• Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939–3948.
   PubMed Web of Science ®Google Scholar
• Glukhov E, Stark M, Burrows LL, Deber CM. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem. 2005;280(40):33960–33967.
   PubMed Web of Science ®Google Scholar